These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37817654)

  • 1. The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis.
    Li Z; Wang X; Li D; Cheng S; Dong Y; Yang H; Li X
    Curr Pharm Des; 2023; 29(29):2323-2335. PubMed ID: 37817654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients.
    Provenzani A; Notarbartolo M; Labbozzetta M; Poma P; Vizzini G; Salis P; Caccamo C; Bertani T; Palazzo U; Polidori P; Gridelli B; D'Alessandro N
    Int J Mol Med; 2011 Dec; 28(6):1093-102. PubMed ID: 21922127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ABCB1 3435C>T Genetic Polymorphism on Pharmacokinetic Variables of Tacrolimus in Adult Renal Transplant Recipients: A Systematic Review and Meta-analysis.
    Peng W; Lin Y; Zhang H; Meng K
    Clin Ther; 2020 Oct; 42(10):2049-2065. PubMed ID: 32888708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
    Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):320-326. PubMed ID: 29603629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III).
    Yoon SH; Cho JH; Kwon O; Choi JY; Park SH; Kim YL; Yoon YR; Won DI; Kim CD
    Transplantation; 2013 Mar; 95(6):828-34. PubMed ID: 23364483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies.
    Li Z; Wang X; Li D; Cheng S; Li Z; Guo H; Dong Y; Zheng Y; Li X
    BMC Nephrol; 2024 Feb; 25(1):48. PubMed ID: 38321419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients.
    Lee J; Huang H; Chen Y; Lu X
    Biopharm Drug Dispos; 2014 Apr; 35(3):164-72. PubMed ID: 24285256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
    Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
    Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.
    Riegersperger M; Plischke M; Steinhauser C; Jallitsch-Halper A; Sengoelge G; Winkelmayer WC; Sunder-Plassmann G; Födinger M
    Clin Lab; 2016 Oct; 62(10):1965-1972. PubMed ID: 28164520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients.
    Provenzani A; Notarbartolo M; Labbozzetta M; Poma P; Biondi F; Sanguedolce R; Vizzini G; Palazzo U; Polidori P; Triolo F; Gridelli B; D'Alessandro N
    Ann Transplant; 2009; 14(1):23-31. PubMed ID: 19289993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients.
    Gómez-Bravo MA; Salcedo M; Fondevila C; Suarez F; Castellote J; Rufian S; Pons JA; Alamo JM; Millán O; Brunet M
    J Clin Pharmacol; 2013 Nov; 53(11):1146-54. PubMed ID: 23900887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population.
    Rahsaz M; Azarpira N; Nikeghbalian S; Aghdaie MH; Geramizadeh B; Moini M; Banihashemi M; Darai M; Malekpour Z; Malekhosseini SA
    Exp Clin Transplant; 2012 Feb; 10(1):24-9. PubMed ID: 22309416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.
    Lee J; Wang R; Yang Y; Lu X; Zhang X; Wang L; Lou Y
    Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):117-25. PubMed ID: 25536375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH; Yoon YD; Park JY; Song EJ; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):109-14. PubMed ID: 22310591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.
    Cusinato DA; Lacchini R; Romao EA; Moysés-Neto M; Coelho EB
    Br J Clin Pharmacol; 2014 Aug; 78(2):364-72. PubMed ID: 24528196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.
    Hawwa AF; McKiernan PJ; Shields M; Millership JS; Collier PS; McElnay JC
    Br J Clin Pharmacol; 2009 Sep; 68(3):413-21. PubMed ID: 19740399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor ABCB1 3435 C>T genetic polymorphisms influence early renal function in kidney transplant recipients treated with tacrolimus.
    Yan L; Li Y; Tang JT; An YF; Wang LL; Shi YY
    Pharmacogenomics; 2016 Feb; 17(3):249-57. PubMed ID: 26784512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients.
    Bonhomme-Faivre L; Picard V; Saliba F; Abbara C; Fodil M; Chaunoy M; Farinotti R
    Am J Health Syst Pharm; 2009 Sep; 66(18):1645-51. PubMed ID: 19729569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms.
    Op den Buijsch RA; Christiaans MH; Stolk LM; de Vries JE; Cheung CY; Undre NA; van Hooff JP; van Dieijen-Visser MP; Bekers O
    Fundam Clin Pharmacol; 2007 Aug; 21(4):427-35. PubMed ID: 17635182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.